Double-blind, randomized, placebo-controlled trial of topiramate plus cognitive-behavior therapy in binge-eating disorder

Journal of Clinical Psychiatry

Volumn 68, Issue 9, 2007, Pages 1324-1332

  Claudino, Angélica M ^a,g   De Oliveira, Irismar R ^b   Appolinario, José Carlos ^c,f   Cordás, Táki A ^d   Duchesne, Monica ^c   Sichieri, Rosely ^e   Bacaltchuk, Josué ^a,f  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^f Janssen Cilag Farmacêutica Ltda   (Brazil)

^g NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM; PLACEBO; THYROID HORMONE; TOPIRAMATE;

ADD ON THERAPY; ADULT; ARTICLE; BACKACHE; BECK DEPRESSION INVENTORY; BINGE EATING DISORDER; BODY MASS; CLINICAL TRIAL; COGNITIVE THERAPY; CONFUSION; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSPEPSIA; DYSURIA; EDEMA; EYE PAIN; FEMALE; HEADACHE; HUMAN; INSOMNIA; LEG PAIN; MAJOR CLINICAL STUDY; MALAISE; MALE; MENTAL DISEASE; MULTICENTER STUDY; NAUSEA; NERVOUSNESS; OBESITY; PARESTHESIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; SIDE EFFECT; SOMNOLENCE; TASTE DISORDER; TOOTH PAIN; TREATMENT OUTCOME; WEIGHT REDUCTION;

EID: 34948850393     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v68n0901     Document Type: Article

References (49)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000
2. Spitzer RL, Devlin MJ, Walsh BT, et al. Binge eating disorder: a multisite field trial of the diagnostic criteria. Int J Eat Disord 1992;11:191-203
3. Spitzer RL, Yanovski SZ, Wadden T, et al. Binge eating disorder: its further validation in a multisite study. Int J Eat Disord 1993;13:137-153
4. Hay P. The epidemiology of eating disorders behaviors: an Australian community based survey. Int J Eat Disord 1998;23:371-382
5. Kinzl JF, Traweger C, Trefalt E, et al. Binge eating disorder in females: a population-based investigation. Int J Eat Disord 1999;25:287-292
6. Fairburn CG, Doll HA, Welch SL, et al. Risk factors for binge eating disorder. Arch Gen Psychiatry 1998;55:425-432
7. Borges MBF, Jorge MJ, Morgan CM, et al. Binge-eating disorder in Brazilian women on a weight-loss program. Obes Res 2002;10:1127-1134
8. Bruce B, Agras WS. Binge eating in females: a population-based investigation. Int J Eat Disord 1992;12:365-373
9. Telch CF, Agras WS, Rossiter EM. Binge eating increases with increasing adiposity. Int J Eat Disord 1988;7:115-119
10. Goldfein JA, Devlin MJ, Spitzer RL. Cognitive behavioral therapy for the treatment of binge eating disorder: what constitutes success? Am J Psychiatry 2000;157:1051-1056
11. Devlin MJ. Binge eating disorder and obesity. Psychiatr Clin North Am 2001;24:325-335
12. Wonderlich SA, de Zwaan M, Mitchell JE, et al. Psychological and dietary treatments of binge eating disorder: conceptual implications. Int J Eat Disord 2003;34(suppl):S58-S71
13. Telch CF, Agras WS, Rossiter EM, et al. Group cognitive-behavioral treatment for the nonpurging bulimic: an initial evaluation. J Consult Clin Psychol 1990;58:629-635
14. Wifley DE, Welch RR, Stein RI, et al. A randomized comparison of group cognitive-behavioral therapy and group interpersonal psychotherapy for the treatment of overweight individuals with binge-eating disorder. Arch Gen Psychiatry 2002;59:713-721
15. National Institute for Clinical Excellence. Eating Disorder: Core Interventions in the Treatment and Management of Anorexia Nervosa, Bulimia Nervosa and Related Eating Disorders. NICE Clinical Guideline, 9. London, UK: National Institute for Clinical Excellence; 2004
16. Wifley DE, Agras SW, Telch CF, et al. Group cognitive-behavioral therapy and group interpersonal psychotherapy for the nonpurging bulimic individual: a controlled comparison. J Consult Clin Psychol 1993;61:296-305
17. Agras SW, Teich CF, Arnow B, et al. Weight loss, cognitive-behavioral, and desipramine treatments in binge eating disorder: an addictive design. Behav Ther 1994;25:225-238
18. Agras WS, Telch CF, Arnow B, et al. One-year follow-up of cognitive-behavioral therapy for obese individuals with binge eating disorder. J Consult Clin Psychol 1997;65:343-347
19. Husted DS, Nathan AS. Binge-eating disorder and new pharmacologic treatments. Prim Psychiatry 2005;12:46-51
20. Carter WP, Hudson JI, Lalonde JK, et al. Pharmacologic treatment of binge eating disorder. Int J Eat Disord 2003;34(suppl):S74-S88
21. Appolinario JC, Bacaltchuk J, Sichieri R, et al. A randomized, double-blind, placebo-controlled study of sibutramine in the treatment of binge eating disorder. Arch Gen Psychiatry 2003;60:1109-1116
22. McElroy SL, Casuto LS, Nelson EB, et al. Placebo-controlled trial of sertraline in the treatment of binge eating disorder. Am J Psychiatry 2000;157:1004-1006
23. McElroy SL, Arnold LM, Shapira NA, et al. Topiramate in the treatment of binge-eating disorder associated with obesity: a randomized, placebo-controlled trial. Am J Psychiatry 2003;160:255-261
24. Arnone D. Review of the use of topiramate for treatment of psychiatric disorders. Ann Gen Psychiatry 2005;4:5
25. McElroy SL, Hudson JI, Capece JA, et al. Topiramate for the treatment of moderate to severe binge eating disorder associated with obesity-a double-blind, placebo-controlled study. Abstracts of the 44th Annual Meeting of the American College of Neuropsychopharmacology; December 11-15, 2005; Waikoloa, Hawaii. Abstract 156
26. Li Z, Maglione M, Tu W, et al. Meta-analysis: pharmacologic treatment of obesity. Ann Intern Med 2005;142:532-546
27. Ricca V, Mannucci E, Mezzani B, et al. Fluoxetine and fluvoxamine combined with individual cognitive-behaviour therapy in binge eating disorder: a one-year follow-up study. Psychother Psychosom 2001;70:298-306
28. Grilo MC, Masheb R, Wilson T. Efficacy of cognitive behavioral therapy and fluoxetine for the treatment of binge eating disorder: a randomized double-blind placebo-controlled comparison. Biol Psychiatry 2005;57:301-309
29. Devlin MJ, Goldfein JA, Jiang H, et al. Cognitive behavioral therapy and fluoxetine as adjunct to group behavioral therapy for binge eating disorder. Obes Res 2005;13:1077-1088
30. Laederach-Hofmann K, Graf C, Horber F, et al. Imipramine and diet counseling with psychological support in the treatment of obese binge eaters: a randomized, placebo-controlled double-blind study. Int J Eat Disord 1999;26:231-244
31. Gormally J, Black S, Daston S, et al. The assessment of binge eating severity among obese persons. Addict Behav 1982;7:47-55
32. Freitas SR, Lopes CS, Appolinario JC, et al. The assessment of binge eating disorder in obese women: a comparison of the Binge Eating Scale with the Structured Clinical Interview for the DSM-IV. Eat Behav 2006;7:282-289
33. Fairburn CG, Marcus MD, Wilson GT. Cognitive-behavioral therapy for binge eating and bulimia nervosa: a comprehensive treatment manual. In: Fairburn CG, Wilson GT, eds. Binge Eating: Nature, Assessment and Treatment. New York, NY: Guilford Press; 1993:371-404
34. Duchesne M, Appolinario JC, Range B, et al. Avaliação da eficácia do Manual de Oxford no tratamento de obesos com transtorno da compulsão alimentar periódica. Arq Bras Endocrinol Metabol 2005;49(suppl 1):576
35. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Edition (SCID-I/P, Version 2.0). New York, NY: Biometric Research, New York State Psychiatric Institute; 1996
36. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59(suppl 20):22-33
37. Gorenstein C, Andrade L. Validation of a Portuguese version of the Beck Depression Inventory and the State-Trait Anxiety Inventory in Brazilian subjects. Braz J Med Biol Res 1996;29:453-457
38. Diggle PJ, Ling KY, Zeger SL. Analysis of Longitudinal Data. Oxford, England: Clarendon Press; 1994
39. Gibbons RD, Hedeker D, Elkin I, et al. Some conceptual and statistical issues in analysis of longitudinal psychiatric data: application to the NIMH Treatment of Depression Collaborative Research Program dataset. Arch Gen Psychiatry 1993;50:739-750
40. Fitzmaurice G. Selected SAS: Applied Longitudinal Data Analysis. 3rd ed. Cary, NC: SAS Institute; 2000
41. Appolinario JC, Bacaltchuk J. Overview of agents with efficacy in binge eating. In: McElroy SL, Allison DB, Bray GA, eds. Obesity and Mental Disorders. New York, NY: Taylor & Francis; 2006
42. Wilson GT, Fairburn CG. Treatments for eating disorders. In: Nathan PE, Gorman JM, eds. A Guide to Treatments That Work, 2nd ed. New York, NY: Oxford University Press; 2002:559-592
43. Fairburn CG, Cooper Z, Doll HA, et al. The natural course of bulimia nervosa and binge eating disorder in young women. Arch Gen Psychiatry 2000;57:659-665
44. Devlin MJ, Yanovsky SZ, Wilson GT. Obesity: what mental health professionals need to know. Am J Psychiatry 2000;157:854-866
45. Milano W, Petrella C, Casella A, et al. Use of sibutramine, an inhibitor of the reuptake of serotonin and noradrenaline, in the treatment of binge eating disorder: a placebo-controlled study. Adv Ther 2005;22:25-31
46. Stefano SC, Bacaltchuk J, Blay SL. et al. Short-term treatment of binge eating disorder with antidepressants: a systematic review. In: New Research Program and Abstracts of the 158th Annual Meeting of the American Psychiatric Association; May 25, 2005: Atlanta, Ga. Abstract NR574:213
47. Bulik CM, Sullivan PF, Kendler KS. Medical and psychiatric morbidity in obese women with and without binge eating. Int J Eat Disord 2002;32:72-78
48. Stunkard AJ, Allison KC. Binge eating disorder: disorder or marker? Int J Eat Disord 2003;34(suppl):S107-S116
49. McElroy SL, Shapira NA, Arnold LM, et al. Topiramate in the long-term treatment of binge eating disorder associated with obesity. J Clin Psychiatry 2004;65:1463-1469